권호기사보기
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
결과 내 검색
동의어 포함
| 번호 | 참고문헌 | 국회도서관 소장유무 |
|---|---|---|
| 1 | Comparative Effectiveness Without Head-to-Head Trials | 미소장 |
| 2 | The Harmonising Outcome Measures for Eczema (HOME) statement to assess clinical signs of atopic eczema in trials | 미소장 |
| 3 | The challenges of determining noninferiority margins: a case study of noninferiority randomized controlled trials of novel oral anticoagulants | 미소장 |
| 4 | Matching-Adjusted Indirect Comparisons: A New Tool for Timely Comparative Effectiveness Research | 미소장 |
| 5 | Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo-controlled, randomized phase III clinical t | 미소장 |
| 6 | Interleukin‐13: Targeting an underestimated cytokine in atopic dermatitis | 미소장 |
| 7 | 2019 Consensus Korean Diagnostic Guidelines to Define Severity Classification and Treatment Refractoriness for Atopic Dermatitis: Objective and Subjective Assessment of Severity | 미소장 |
| 8 | Alternative weighting schemes when performing matching‐adjusted indirect comparisons | 미소장 |
| 9 | A Matching-Adjusted Indirect Comparison of Pembrolizumab + Chemotherapy vs. Nivolumab + Ipilimumab as First-Line Therapies in Patients with PD-L1 TPS ≥1% Metastatic NSCLC | 미소장 |
| 10 | Comparative efficacy and safety of systemic therapies used in moderate‐to‐severe atopic dermatitis: a systematic literature review and network meta‐analysis | 미소장 |
| 11 | Short-Term Effectiveness and Safety of Biologics and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review and Network Meta-Analysis | 미소장 |
| 12 | Tralokinumab plus topical corticosteroids in adults with severe atopic dermatitis and inadequate response to or intolerance of ciclosporin A: a placebo‐controlled, randomized, phase III clinical trial (ECZTRA 7)* | 미소장 |
| 13 | Interpretation of EASI-75 from a patient perspective—A post hoc analysis from a phase 2b trial of dupilumab in adults with moderate-to-severe atopic dermatitis | 미소장 |
| 14 | Matching-Adjusted Indirect Comparison (MAIC) of Tepotinib with Other MET Inhibitors for the Treatment of Advanced NSCLC with MET Exon 14 Skipping Mutations | 미소장 |
| 15 | Comparative Efficacy and Safety of Monoclonal Antibodies and Janus Kinase Inhibitors in Moderate-to-severe Atopic Dermatitis: A Systematic Review and Meta-analysis | 미소장 |
| 16 | Efficacy and safety of abrocitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: a randomised, double-blind, multicentre phase 3 trial | 미소장 |
| 17 | The efficacy and safety of IL-13 inhibitors in atopic dermatitis: A systematic review and meta-analysis | 미소장 |
| 18 | European guideline (EuroGuiDerm) on atopic eczema: part I – systemic therapy | 미소장 |
| 19 | Non‐biologic systemic treatments for atopic dermatitis: Current state of the art and future directions | 미소장 |
*표시는 필수 입력사항입니다.
| 전화번호 |
|---|
| 기사명 | 저자명 | 페이지 | 원문 | 기사목차 |
|---|
| 번호 | 발행일자 | 권호명 | 제본정보 | 자료실 | 원문 | 신청 페이지 |
|---|
도서위치안내: / 서가번호:
우편복사 목록담기를 완료하였습니다.
*표시는 필수 입력사항입니다.
저장 되었습니다.